Health Care • Medical/Nursing Services
$6.65 ▲ +0.01
(+0.15%)
MKT CAP: $677.7M • VOL: 1.11M
52W L $2 52W H $7
STLN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $502.7M | $393.4M | $324.2M |
| YoY Revenue Growth % | +27.8% | +21.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$36.1M | -$60.1M | -$77.0M |
| Operating Margin % | -7.2% | -15.3% | -23.8% |
| Net Income (GAAP) | $60.61B | $64.66B | -$83.1M |
| EBITDA (Normalized) | -$33.5M | -$57.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$24.6M | -$26.5M | -$36.3M |
| Capital Expenditures (CapEx) | $3.2M | $3.8M | — |
| Free Cash Flow (FCF) | -$27.8M | -$30.3M | -$36.3M |
| FCF Margin % | -5.5% | -7.7% | -11.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $77.4M | $93.1M | — |
| Total Stockholders' Equity | -$15.7M | $3.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR STLN.